{"nct_id":"NCT02939989","title":"Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study","status":"COMPLETED","status_verified_date":"2022-04","start_date":"2016-11-21","start_date_type":"ACTUAL","primary_completion_date":"2021-05-07","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-30","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}